Inhibition of VDAC1 Rescues Aβ 1-42-Induced Mitochondrial Dysfunction and Ferroptosis via Activation of AMPK and

Xinpei Zhou1, Ximin Tang1, Tao Li2

  • 1Department of Human Anatomy, College of Basic Medicine, Dali University, Xiaguan Campus of Dali University, Wanhua Road, Dali City, Yunnan Province, China.

Mediators of Inflammation
|February 23, 2023
PubMed

Insights

Inhibition of Voltage-dependent anion channel 1 (VDAC1) reduces neuronal damage in Alzheimer's disease (AD) models. Blocking VDAC1 alleviates mitochondrial dysfunction and ferroptosis by activating key cellular pathways.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is characterized by beta-amyloid (Aβ) accumulation, leading to neuronal mitochondrial dysfunction and ferroptosis.
  • Voltage-dependent anion channel 1 (VDAC1) is implicated in mitochondrial dysfunction and ferroptosis, but its precise role in AD pathogenesis is unclear.

Purpose of the Study:

  • To investigate the mechanism by which VDAC1 regulates mitochondrial dysfunction and ferroptosis in neurons within an Alzheimer's disease model.
  • To explore the therapeutic potential of VDAC1 inhibition in mitigating AD-related neuronal damage.

Main Methods:

  • Assessed cell viability (MTT assay) and neuronal damage markers (LDH, GPX4, SOD, MDA, ROS, MMP) in Aβ-treated PC12 cells.
  • Utilized Morris water maze test to evaluate memory in AD mice models.
  • Analyzed the expression of key signaling pathways (AMPK/mTOR, Wnt/β-catenin) and VDAC1 via Western blotting.

Main Results:

  • Aβ treatment decreased cell viability, increased LDH release, and altered levels of GPX4, SOD, MDA, ROS, and MMP in PC12 cells.
  • VDAC1 expression was elevated in brain tissue of AD mice and Aβ-treated PC12 cells.
  • Inhibition of VDAC1 reversed Aβ-induced detrimental effects and activated AMPK/mTOR and Wnt/β-catenin pathways.

Conclusions:

  • VDAC1 plays a critical role in mediating mitochondrial dysfunction and ferroptosis in AD neurons.
  • Inhibiting VDAC1 demonstrates a neuroprotective effect by restoring mitochondrial function and preventing ferroptosis.
  • VDAC1 inhibition represents a potential therapeutic strategy for Alzheimer's disease, acting through the AMPK/mTOR and Wnt/β-catenin signaling pathways.